Dr.
Biagio Barone
Urologo
·
Andrologo
Chirurgo
Altro
sulle specializzazioni
Napoli 1 indirizzo
Esperienze
Il dottor Biagio Barone è specialista in Urologia e Andrologia. La sua carriera è caratterizzata da un profondo impegno nel fornire diagnosi precise e trattamenti avanzati per pazienti affetti da patologie urologiche, andrologiche e uro-oncologiche. Il dottor Barone ha conseguito la sua specializzazione in Urologia e Andrologia con lode e massimo dei voti presso l'Università degli Studi di Napoli Federico II. Durante il suo percorso di formazione, ha frequentato l'Ospedale Buonconsiglio Fatebenefratelli di Napoli e l'Ospedale del Mare di Napoli, dove ha perfezionato le sue competenze nelle tecniche di chirurgia mini invasiva endoscopica, laparoscopica e robot-assistita. La sua dedizione all'eccellenza professionale lo ha portato a collaborare in ambito scientifico con i centri di maggiore prestigio a livello nazionale ed internazionale per trials clinici, linee guida e nuovi protocolli diagnostici-terapeutici. Questa formazione avanzata gli ha permesso di acquisire competenze specializzate nella gestione delle patologie urologiche più complesse. Dal Giugno 2023 ha lavorato come Dirigente Medico in Urologia presso l'Azienda Ospedaliera di Rilevanza Nazionale "Sant'Anna e San Sebastiano" di Caserta. Attualmente, il dottor Barone ricopre la posizione di Dirigente Medico in Urologia presso il Presidio Ospedaliero "San Paolo" dell'ASL Napoli 1 Centro. Nel 2021 ha conseguito l’abilitazione andrologica nazionale presso la Società Italiana di Andrologia. Il dottor Barone è un membro attivo di numerose società scientifiche italiane ed europee, dimostrando un costante impegno nel rimanere aggiornato sulle ultime scoperte e tendenze nella sua disciplina. Ha partecipato e continua a partecipare a convegni e congressi nazionali ed internazionali al fine di continuare a perfezionare le sue tecniche chirurgiche e le conoscenze nel campo dell'urologia, dell'andrologia e dell’uro-oncologia. Il dottor Barone è inoltre un autore prolifico, con oltre cento articoli scientifici pubblicati su rinomate riviste scientifiche internazionali, con focus su argomenti come il tumore vescicale, il tumore prostatico, il tumore renale, l'urolitiasi, le disfunzioni sessuali e l'infertilità. Nel Dicembre del 2023 ottiene l'Abilitazione Scientifica Nazionale alle funzioni di professore universitario di seconda fascia. Ad Ottobre 2024 è stato inserito nella classifica mondiale dei migliori ricercatori nel World’s Top 2% Scientist, posizione confermata e migliorata ad Ottobre 2025.
Aree di competenza principali:
- Andrologia
- Chirurgia endoscopica
- Urologia
Principali patologie trattate
- Prostatite
- Iperplasia prostatica benigna
- Calcolosi Renale
- Infezione delle vie urinarie
- Cistite
- +25 a11y_sr_more_diseases
Presso questo indirizzo visito
Foto e video
Esperienze
Biagio Barone
urologo, andrologo, chirurgo
Tirocini
- Ospedale del Mare - ASL Napoli 1 Centro (Napoli)
- Ospedale Buon Consiglio Fatebenefratelli (Napoli)
Formazione
- Università degli Studi di Napoli Federico II
Certificati
Patologie trattate
- Prostatite
- Iperplasia prostatica benigna
- Calcolosi Renale
- Infezione delle vie urinarie
- Cistite
- Cistite interstiziale
- Pielonefrite
- Ematuria
- Condiloma acuminato
- Varicocele
- Infertilità
- Incontinenza urinaria
- Tumori della vescica urinaria
- Tumore del testicolo
- Carcinoma della prostata
- Carcinoma del rene
- Malattia di La Peyronie
- Eiaculazione precoce
- Disfunzione erettile
- Infezione urinaria
- Ipogonadismo
- Andropausa
- Criptorchidismo
- Fimosi
- Colica renale
- Uretrite
- Frenulo breve
- Congestione prostatica
- Ostruzione delle vie urinarie
- Calcolosi Ureterale
Competenze linguistiche
- Inglese
- Italiano
Pubblicazioni
- Stone residual fragments: A thorny problem (Urologia Journal, 2019)
- Hyperparathyroidism and nephrolithiasis in patients with paget’s disease of bone (European Urology Supplements, 2019)
- Osteoporosis is a risk factor for nephrolithiasis in an adult Caucasian population (European Urology Supplements, 2019)
- Monolateral recurrent soft urolithiasis: Case report and stone analysis (European Urology Supplements, 2019)
- Risk factors for nephrolithiasis in patients with metabolic bone disorders and hypovitaminosis D: Effects of cholecalciferol supplementation (European Urology Supplements, 2019)
- Metabolic risk factors for nephrolithiasis in patients with paget’s disease of bone (European Urology Supplements, 2019)
- Retrograde Intra Renal Surgery (RIRS) versus Percutaneous Nephrolithotomy (PCNL) for renal stones >2cm. A systematic review and meta-analysis (Minerva Urologica e Nefrologica, 2020)
- Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review. (International Journal of Environmental Research and Public Health, 2020)
- Granulomatous prostatitis: a challenging differential diagnosis to take into consideration (Future Oncology, 2020)
- Granulomatous prostatitis mimicking prostate cancer in a patient with psoriatic arthritis: a case report (Future Science OA, 2020)
- The COVID-19 Pandemic: Is It A Wolf Consuming Fertility? (International Journal of Fertility and Sterility, 2020)
- Osteoporosis is a Predictive Factor for Nephrolithiasis in an Adult Free‑Living Caucasian Population From Southern Italy: A Longitudinal Retrospective Study Based on a General Practice Database (Calcified Tissue International, 2020)
- A case of incidentally discovered solitary fibrous tumor of the kidney: A case study (Molecular and Clinical Oncology, 2020)
- The association between Burning Mouth Syndrome and Urologic Chronic Pelvic Pain Syndrome: a case‐control study (Journal of Oral Pathology and Medicine, 2020)
- The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay? (Nutrients, 2020)
- Inguinal Lymphadenectomy (IL) in penile cancer patients: comparison with laparoscopic (LIL) and open (OIL) techniques. Multicenter analysis with a median follow up of 5 years (European Urology Open Science, 2020)
- Metabolic syndrome is associated to an increased risk of low bone mineral density in free-living women with suspected osteoporosis (Journal of Endocrinological Investigation, 2020)
- New technique for bladder neck reconstruction during robot assisted radical prostatectomy and its impact on early continence recovery: exploiting bowel suture technique for urological purpose. (Minerva Urologica e Nefrologica, 2020)
- The role of multiparametric resonance and biopsy in prostate cancer detection: comparison with definitive histological report after laparoscopic/robotic radical prostatectomy (Abdominal Radiology, 2020)
- Urologic malignancies: advances in the analysis and interpretation of clinical findings (Future Science OA, 2021)
- Hypogonadism in Patients with Prader Willi Syndrome: A Narrative Review (International Journal of Molecular Sciences, 2021)
- Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy (Future Science OA, 2021)
- Step-by-Step New Technique for Bladder Neck Reconstruction During Robot-Assisted Radical Prostatectomy: Adapting a Bowel Suture Technique for a Urologic Purpose (Videourology, 2021)
- BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored (Diagnostics, 2021)
- Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study (Future Science OA, 2021)
- The Comparison of Imaging and Clinical Methods to Estimate Prostate Volume: A Single-Centre Retrospective Study (Urologia Internationalis, 2021)
- Metabolic syndrome is not associated to an increased risk of low bone mineral density in men at risk for osteoporosis (Journal of Endocrinological Investigation, 2021)
- Impact of Sexual Activity on the Risk of Male Genital Tumors: A Systematic Review of the Literature (International Journal of Environmental Research and Public Health, 2021)
- Urinary Incontinence after Planned Cesarean Hysterectomy for Placenta Accreta (Urologia Internationalis, 2021)
- Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression? (Frontiers in Oncology, 2021)
- Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization (International Journal of Molecular Sciences, 2021)
- Preoperative fibrinogen-to-albumin ratio as independent predictor of bladder cancer (European Urology Open Science, 2021)
- Reliability of mpMRI in patients with a previous negative biopsy: comparison with biopsy naïve patients in the detection of clinically significant cancer (European Urology Open Science, 2021)
- Effects of virtual reality on perceived pain during transrectal biopsy (European Urology Open Science, 2021)
- The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis (Cancers, 2021)
- Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature (Nutrients, 2021)
- COVID-19 and prostate cancer: A complex scenario with multiple facets (Future Science OA, 2021)
- Correlation between Ion Composition of Oligomineral Water and Calcium Oxalate Crystal Formation (Crystals, 2021)
- Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis (Clinical Genitourinary Cancer, 2021)
- Liquid biopsy in bladder cancer: State of the art and future perspectives (Critical Reviews in Oncology/Hematology, 2022)
- Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors (International Journal of Molecular Sciences, 2022)
- A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer (Diagnostics, 2022)
- Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette–Guerin Immunotherapy (Diagnostics, 2022)
- Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study (Journal of physiology and pharmacology: an official journal of the Polish Physiological Society, 2022)
- Bilateral calcified Macroplastique® after 12 years (Asian Journal of Urology, 2022)
- The Management of Clinical Varicocele: Robotic Surgery Approach (Frontiers in Reproductive Health, 2022)
- The Role of Testosterone in the Elderly: What Do We Know? (International Journal of Molecular Sciences, 2022)
- Minimally invasive simple prostatectomy: Robotic-assisted versus laparoscopy. A comparative study (Archivio Italiano di Urologia, Andrologia, 2022)
- Lower urinary tract symptoms and mental health during COVID-19 pandemic (Archivio Italiano di Urologia, Andrologia, 2022)
- ProACT in the management of stress urinary incontinence after radical prostatectomy. What happens after 8 years of follow up? monocentric analysis in 42 patients (Journal of Basic and Clinical Physiology and Pharmacology, 2022)
- Psychological impact of abnormally invasive placenta: an underestimated and hidden morbidity (Journal of Basic and Clinical Physiology and Pharmacology, 2022)
- Erectile and sexual dysfunction in male and female patients with celiac disease: A cross‐sectional observational study (Andrology, 2022)
- Sexual Dysfunction in Patients with Coeliac Disease: a cross-sectional study (Digestive and Liver Disease, 2022)
- Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review (Cancers, 2022)
- New Possibilities in Heart Failure: The Effects of Tadalafil on Diastolic Function in Patients Undergoing Robot-Assisted Radical Prostatectomy (Applied Sciences, 2022)
- Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer (Urologic Oncology, 2022)
- Abnormal presentation of a bilateral, synchronous and plurimetastatic medium and large cell testicular lymphoma: A case report (Molecular and Clinical Oncology, 2022)
- Heavy Metal Pollution and Male Fertility: An Overview on Adverse Biological Effects and Socio-Economic Implications (Endocrine Metabolic & Immune Disorders, 2022)
- Sexual dysfunction in gastroenterological patients: Do gastroenterologists care enough? A nationwide survey from the Italian Society of Gastroenterology (SIGE) (Digestive and Liver Disease, 2022)
- Erectile dysfunction and mobile phone applications: Quality, content and adherence to European Association guidelines on male sexual dysfunction (Archivio Italiano di Urologia, Andrologia, 2022)
- Radiomics in prostate cancer: an up-to-date review (Therapeutic Advances in Urology, 2022)
- Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives (Cancers, 2022)
- The relationship between obstructive sleep apnoea and erectile dysfunction: An underdiagnosed link? A prospective cross‐sectional study (Andrologia, 2022)
- Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer (Diagnostics, 2022)
- Preoperative monocyte-to-lymphocyte ratio as a potential predictor of bladder cancer (Journal of Basic and Clinical Physiology and Pharmacology, 2022)
- Sexual Desire, mood disorders and sleep disturbances in female BMS patients: a controlled study (Journal of Oral Pathology and Medicine, 2022)
- Premature ejaculation in the era of mobile health application: A current analysis and evaluation of adherence to EAU guidelines (Archivio Italiano di Urologia, Andrologia, 2022)
- Natural treatments for erectile dysfunction: A focus on mobile health applications (Archivio Italiano di Urologia, Andrologia, 2022)
- The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk? (Cancers, 2022)
- Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG (Minerva Urologica e Nefrologica, 2022)
- Ejaculation sparing thulium laser enucleation of the prostate: a observational prospective study (European Urology Open Science, 2022)
- Combined treatment of low-intensity extracorporeal shockwave therapy and platelet-rich plasma on erectile dysfunction – a pilot study (European Urology Open Science, 2022)
- Robot-assisted partial nephrectomy versus percutaneous ablation for completely endophytic renal masses: a multicenter analysis with a minimum 3-year follow-up (European Urology Open Science, 2022)
- Preoperative Fibrinogen-to-Albumin Ratio as Potential Predictor of Bladder Cancer: A Monocentric Retrospective Study (Medicina, 2022)
- Ejaculation Sparing Thulium Laser Enucleation of the Prostate: An Observational Prospective Study (Journal of Clinical Medicine, 2022)
- Intestinal microbiota, intestinal permeability and the urogenital tract: is there a pathophysiological link? (Journal of physiology and pharmacology: an official journal of the Polish Physiological Society, 2022)
- Peyronie’s disease: where are we at? (Journal of Basic and Clinical Physiology and Pharmacology, 2022)
- Micro-Ultrasound in the Diagnosis and Staging of Prostate and Bladder Cancer: A Comprehensive Review (Medicina, 2022)
- The Robotic Intracorporeal Vesuvian Orthotopic Neobladder (VON)—A New Technique for Continent Urinary Diversion: Initial Experience and Description of the Technique (Applied Sciences, 2022)
- Male infertility, what Mobile Health Applications “know”: quality analysis and adherence to European Association of Urology Guidelines (Archivio Italiano di Urologia, Andrologia, 2022)
- Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study (Current Urology, 2023)
- Voice Assistants as Consultants for Male Patients with Sexual Dysfunction: A Reliable Option? (International Journal of Environmental Research and Public Health, 2023)
- Molecular Imaging Diagnosis of Renal Cancer Using 99m Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques (Diagnostics, 2023)
- Peyronie’s disease and metabolic syndrome. An understudied link? (European Urology, 2023)
- A Novel Low-Cost Uroflowmetry for Patient Telemonitoring (International Journal of Environmental Research and Public Health, 2023)
- Mobile health applications in kidney stone disease management: A reliable support for patients? (Archivio Italiano di Urologia, Andrologia, 2023)
- Vitamin D, a Regulator of Androgen Levels, Is Not Correlated to PSA Serum Levels in a Cohort of the Middle Italy Region Participating to a Prostate Cancer Screening Campaign (Journal of Clinical Medicine, 2023)
- Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects (International Journal of Molecular Sciences, 2023)
- Bladder Cancer and Risk Factors: Data from a Multi-Institutional Long-Term Analysis on Cardiovascular Disease and Cancer Incidence (Journal of Personalized Medicine, 2023)
- Inguinal lymphadenectomy in penile cancer patients: a comparison between open and video endoscopic approach in a multicenter setting (Journal of Basic and Clinical Physiology and Pharmacology, 2023)
- The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications (European Thyroid Journal, 2023)
- Risk Factors for Testicular Cancer: Environment, Genes and Infections—Is It All? (Medicina, 2023)
- The Efficacy of Flogofilm ® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial (Journal of Clinical Medicine, 2023)
- Cytoreductive Nephrectomy and Metastatic Renal Cell Carcinoma: State of the Art and Future Perspectives (Medicina, 2023)
- Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review (Therapeutic Advances in Urology, 2023)
- Predictors of efficacy of immune checkpoint inhibitors in patients with advanced urothelial carcinoma: a systematic review and meta-analysis (Clinical Genitourinary Cancer, 2023)
- Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer (Diagnostics, 2023)
- Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: An Italian case control study (Continence, 2023)
- Comparing Cardiovascular Adverse Events in Cancer Patients: A Meta-analysis of Combination Therapy with Angiogenesis Inhibitors and Immune Checkpoint Inhibitors versus Angiogenesis Inhibitors Alone (Critical Reviews in Oncology/Hematology, 2023)
- Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement (Diagnostics, 2023)
- Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma (Clinical Genitourinary Cancer, 2023)
- Novel Key Ingredients in Urinary Tract Health—The Role of D-mannose, Chondroitin Sulphate, Hyaluronic Acid, and N-acetylcysteine in Urinary Tract Infections (Uroial PLUS®) (Nutrients, 2023)
- Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study (Digestive and Liver Disease, 2023)
- Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identification (Expert Review of Molecular Diagnostics, 2023)
- The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives (Medicina, 2023)
- Which inflammatory marker, between systemic immune-inflammation index and neutrophil to eosinophil ratio, is associated with Peyronie’s disease and are there any implications for a better understanding of its mechanisms? (Basic and Clinical Andrology, 2023)
- Carbapenem-Resistant Enterobacteriaceae in Urinary Tract Infections: From Biological Insights to Emerging Therapeutic Alternatives (Medicina, 2024)
- Preoperative Albumin-to-Alkaline Phosphatase Ratio as an Independent Predictor of Lymph Node Involvement in Penile Cancer (Medicina, 2024)
- The Impact of Venous Thromboembolism on Upper Tract Urothelial Carcinomas Undergoing Open or Minimally Invasive Radical Nephroureterectomy in the USA: Perioperative Outcomes and Health Care Costs from Insurance Claims Data (European Urology Focus, 2024)
- The Role of MUC1 in Renal Cell Carcinoma (Biomolecules, 2024)
- From Dr. Google to CE-marked medical devices: need for ethical and legal safeguards (Journal of Basic and Clinical Physiology and Pharmacology, 2024)
- Unlocking Precision Medicine: Liquid Biopsy Advancements in Renal Cancer Detection and Monitoring (International Journal of Molecular Medical Science, 2024)
- Advances in Urinary Diversion: From Cutaneous Ureterostomy to Orthotopic Neobladder Reconstruction: A Comprehensive Review (Journal of Personalized Medicine, 2024)
- Ischemia-Reperfusion Injury in Kidney Transplantation: Mechanisms and Potential Therapeutic Targets (International Journal of Molecular Sciences, 2024)
- PD02-05 THE IMPACT OF VENOUS THROMBOEMBOLISM ON MUSCLE INVASIVE BLADDER CANCER (MIBC) PATIENTS UNDERGOING OPEN OR MINIMALLY-INVASIVE RADICAL CYSTECTOMY IN THE UNITED STATES: PERIOPERATIVE OUTCOMES AND HEALTH-CARE COSTS FROM INSURANCE CLAIMS DATA (The Journal of Urology, 2024)
- Early and late post-procedural complications in different orthotopic neobladder surgical approaches: A systematic review (Surgical Oncology, 2024)
- "Adiponcosis interplay: adipose tissue, microenvironment and prostate cancer" (Journal of Basic and Clinical Physiology and Pharmacology, 2024)
- 23 - One-year outcomes after water vapor thermal therapy in frail patients with urinary retention and catheter dependency (Continence, 2024)
- 69 - Water vapor therapy (Rezum®) for symptomatic BPH: A safe and effective treatment for patients with gland over 80 mL. 1 year results from an Italian monocentric prospective study (Continence, 2024)
- The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costs (Minerva Urology and Nephrology, 2024)
- The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study (The Prostate, 2024)
- Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors (Diagnostics, 2024)
- Comparison of Current International Guidelines on Premature Ejaculation: 2024 Update (Diagnostics, 2024)
- Efficacy and Safety of Boldine Combined with Phyllanthus niruri and Ononis spinosa in Medical Expulsive Therapy for Distal Ureteral Stones with Renal Colic: A Single-Center, Retrospective Cohort Study (Medicina, 2024)
- Ureteral access sheaths in RIRS: a retrospective, comparative, single-center study (Journal of Basic and Clinical Physiology and Pharmacology, 2024)
- Female sexual dysfunctions in multiple sclerosis patients with lower urinary tract symptoms: an Italian case-control study (Sexual Medicine, 2024)
- Sexual Dysfunctions and Gynecomastia in Male Rheumatological Patients Treated with Methotrexate: A Systematic Review (Journal of Clinical Medicine, 2024)
- Water vapor thermal therapy (Rezūm System) in patients with large prostates: results from a prospective comparative study (Minerva Urology and Nephrology, 2024)
- Sexual dysfunctions in inflammatory bowel disease: role of Mediterranean diet and quality of life (Andrology, 2024)
- Impact of smoking exposure on disease progression in high risk and very high-risk nonmuscle invasive bladder cancer patients undergoing BCG therapy (Urologic Oncology Seminars and Original Investigations, 2024)
- Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach (Minerva Urology and Nephrology, 2024)
- HoloLens platform for healthcare professionals simulation training, teaching, and its urological applications: an up-to-date review (Therapeutic Advances in Urology, 2024)
- The Correlation Between Body Mass Index and Prostate Volume: A Retrospective Analysis of Pre and Postoperative Measurements in Prostate Cancer Patients (The Prostate, 2024)
- Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre series (World Journal of Urology, 2024)
- The impact of preoperative venous thromboembolism on patients undergoing TURBT: Perioperative outcomes and healthcare costs from US insurance claims data (BJUI Compass, 2025)
- The Role of Butirprost® as an Adjuvant in Enhancing the Effect of Antibiotics in Patients Affected by Chronic Bacterial Prostatitis: A Randomized Prospective Trial (Medicina, 2025)
- Nuevos factores de riesgo de tromboembolismo venoso (TEV) después de la resección transuretral de tumor vesical (RTU): modelos de regresión multivariable escalonada y LASSO basados en datos de reclamaciones de seguros de EE. UU (Actas Urológicas Españolas, 2025)
- New biomarkers for diagnosis of bladder cancer: a bibliometric analysis (Archivio italiano di urologia, andrologia: organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia, 2025)
- Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database (Actas Urológicas Españolas (English Edition), 2025)
- The impact of the Tumor microenvironment in the Dual Burden of Obesity-Cancer link (Seminars in Cancer Biology, 2025)
- Technical Modifications Employed in RARP to Improve Early Continence Recovery: A Literature Review (Life, 2025)
- Preoperative platelet-to-lymphocyte ratio as a predictor of inguinal lymph node metastasis in penile cancer (Archivio italiano di urologia, andrologia: organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia, 2025)
- Which Surrogate Marker of Insulin Resistance Among Those Proposed in the Literature Better Predicts the Presence of Non-Metastatic Bladder Cancer? (Journal of Clinical Medicine, 2025)
Premi e riconoscimenti
- CLU Best Poster Award (European Association of Urology, 2019)
- Premio SIU Andrea Tamagnone (Società Italiana di Urologia, 2023)
Prestazioni e prezzi
-
Visita andrologica
100 € -
-
Visita urologica
100 € -
-
Visita andrologica + ecografia
130 € -
-
Visita urologica + ecografia
130 € -
-
Consulenza online
50 € -
-
-
Indirizzi (2)
Consulenza online
Disponibilità
Pagamento online accettato
Risparmia tempo prima della visita.
Modalità di pagamento (visite private)
- Pagamento online accettato
- Carta di credito
- Carta di debito
- Carta prepagata
Telefono
Telefono
Consulenza online
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Tempo medio di risposta:
Telefono
Consulenza online
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Tempo medio di risposta:
Via Alessio Mazzocchi 37, Napoli 80141
Disponibilità
Modalità di pagamento (visite private)
- Contanti
- Carta di credito
- Carta di debito
- Carta prepagata
Telefono
Telefono
Studio Medico Barone
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Tempo medio di risposta:
Telefono
Studio Medico Barone
Risparmia tempo! Prenota online:
Prenota senza telefonare e senza costi aggiuntivi, selezionando una data disponibile. Dopo la prenotazione riceverai email di conferma e promemoria tramite SMS.
Tempo medio di risposta:
Convenzioni assicurative non attive
Questo dottore accetta solo pazienti privati. Verrà richiesto un pagamento da parte tua per la prestazione o puoi ricercare un altro dottore che abbia una convenzione con la tua assicurazione
Recensioni
206 recensioni
Più menzionato dai pazienti
- Spiegazioni dettagliate
- Attenzione durante la visita
- Puntualità
-
G
G.P.
Il dott. Barone è una persona molto empatica ed estremamente preparata, non si fatica a sentirsi a proprio agio nonostante questo tipo di visita possa creare un po' di imbarazzo. Puntuale rispetto dell'orario dell'appuntamento e ampia disponibilità a fornire risposte a tutti i quesiti posti. Negli anni ho incontrato diversi professionisti del settore, è proprio alla luce di ciò mi sento di consigliarlo vivamente.
• Studio Medico Barone • visita urologica •
-
M
Marano Caterina
bravo, competente e soprattutto gentile, e molto vicino al paziente
• Studio Medico Barone • visita urologica •
-
G
G.L.
Per me era la prima esperienza con una consulenza online e, inizialmente, ero un po' scettico. Mi sono però dovuto ricredere: il dott. Barone si è dimostrato estremamente competente, professionale ed empatico. È riuscito a mettermi subito a mio agio e ha risposto con chiarezza a tutte le mie domande.
• Consulenza online • consulenza online •
-
M
Massimiliano De Luca
Visita accurata , il dottore e’ stato chiaro e disponile
• Studio Medico Barone • visita urologica + ecografia •
-
F
F.V.
Eccellente, grande professionalità ,trasmette grande empatia
• Studio Medico Barone • visita urologica •
-
G
G.E.
l'Italia vanta ancora eccellenze in campo medico, il Dott. Barone ne è un esempio
• Studio Medico Barone • visita urologica •
-
G
Gennaro
Molto bravo ed empatico .Ottima terapia e spiegazioni dettagliate
• Studio Medico Barone • visita urologica •
Dr. Biagio Barone
Gentile Gennaro, la ringrazio per il suo feedback. Sono felice che abbia trovato la terapia ottima e le spiegazioni dettagliate, e che abbia apprezzato l'empatia. Resto a disposizione per il futuro.
Cordiali saluti
-
L
Luigi
Oltre alla bravura professionale il dott. Barone mostra calma e gentilezza tanto da mettere il paziente a proprio agio. Una qualità non indifferente che completa la.persona oltre il professionista.
• Studio Medico Barone • visita urologica •
Dr. Biagio Barone
Gentile Luigi, la ringrazio di cuore per le sue belle parole. Apprezzo particolarmente che abbia sottolineato come calma e gentilezza completino la persona oltre il professionista. Per me è importante che il paziente si senta a proprio agio non solo grazie alla competenza tecnica, ma anche per come viene accolto e ascoltato. Grazie per la fiducia e resto a disposizione.
Cordiali saluti
-
C
Claudio
Gentile e preparato ,spiega tutto molto bene . Contento della scelta.
• Consulenza online • consulenza online •
Dr. Biagio Barone
Gentile Claudio, la ringrazio per il suo feedback. Sono contento che sia soddisfatto della scelta e che abbia apprezzato gentilezza, preparazione e chiarezza nelle spiegazioni. Resto a disposizione per qualsiasi necessità futura.
Cordiali saluti
-
A
A.M.
Il Dottor Barone e un medico eccezionale.Oltre alla grandissima professionalità,si distingue per la sua empatia e disponibilità verso il paziente.Consigliatissimo
• Studio Medico Barone • visita urologica + ecografia •
Dr. Biagio Barone
La ringrazio di cuore per le sue parole. Essere definito "eccezionale" è per me un grande onore. Sono felice che abbia apprezzato non solo la professionalità, ma soprattutto l'empatia e la disponibilità, che ritengo fondamentali nel rapporto con il paziente. Grazie per il consiglio e per la fiducia.
A disposizione sempre
Informazioni sul prezzo
Consulenza online
I prezzi di alcune prestazioni possono variare a seconda del singolo caso. Dopo aver effettuato una prenotazione, puoi chiedermi il prezzo di una specifica prestazione inviandomi un messaggio privato. Prenota ora la data più adatta alle tue esigenze.
Tempo medio di risposta:
Informazioni sul prezzo
Studio Medico Barone
I prezzi di alcune prestazioni possono variare a seconda del singolo caso. Dopo aver effettuato una prenotazione, puoi chiedermi il prezzo di una specifica prestazione inviandomi un messaggio privato. Prenota ora la data più adatta alle tue esigenze.
Tempo medio di risposta: